
Beefing Up Cancer Treatments, With A Vaccine In Sight
February 18th, 2022
Beefing Up Cancer Treatments, With A Vaccine In Sight
February 18th, 2022
APDN, EvviVax Announce Publication of Positive Preclinical Data for Linear DNA™ Platform Approach to Cancer Immunotherapy
February 17th, 2022
‘Linear DNA’ Combo Shows Punch In Cancer Fight
September 20th, 2019
Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
March 1st, 2019
LineaRx agreement with Takis and Evvivax for cancer vaccines
September 21st, 2018
Pharmaceutical Technology | LineaRx signs drug development agreement with Takis
September 21st, 2018
LineaRx to Collaborate with Takis and Evvivax on Cancer Vaccines
September 20th, 2018
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20th, 2018